Yes, as with other incretin-based therapies, nausea, diarrhea, and reduced appetite are among the most commonly reported side effects, especially during dose escalation
Mechanism-based antidiabetic activity of fructo- and isomalto-oligosaccharides: Validation by in vivo , in silico and in vitro interaction potential
Kaiser's regional structure means PA criteria can vary meaningfully between regions
Keep a consistent schedule for meals and exercise
I'd hesitate (soft for: strongly advice against) drawing conclusions from this sort of research, but instead use it as a screening tool
Some gastroenterologists have prescribed GLP-1 receptor agonists to patients with well-controlled IBD, particularly when metabolic benefits outweigh theoretical risks